Department of Ophthalmology and Visual Sciences, College of Medicine, University of Iowa, Iowa City.
Department of Biostatistics, College of Public Health, University of Iowa, Iowa City.
JAMA Ophthalmol. 2014 Jan;132(1):13-22. doi: 10.1001/jamaophthalmol.2013.5515.
Understanding the natural history of visual outcome in branch retinal vein occlusion (BRVO) is fundamental to its management.
To investigate the natural history of visual outcome in major and macular BRVO.
DESIGN, SETTING, AND PARTICIPANTS: Observational cohort study at a university-based referral practice from 1973 until 1999. The study comprised 216 consecutive eyes with BRVO (144 eyes with major and 72 eyes with macular BRVO) seen within 3 months of onset.
At first visit, all patients had a detailed ophthalmic and medical history and comprehensive ophthalmic evaluation. Ophthalmic evaluation at initial and follow-up visits included recording best-corrected visual acuity (VA) using the Snellen VA chart and visual fields with a Goldmann perimeter.
Best-corrected VA and visual field outcome on follow-up.
The median time to macular edema resolution was 21 months in those with major BRVO and 18 months in those with macular BRVO. Overall, for eyes with initial VA of 20/60 or better, VA improved or remained stable in 75% (95% CI, 63%-86%) for major BRVO and 86% (95% CI, 73%-95%) for macular BRVO. In those with initial VA of 20/70 or worse, VA improved in 69% (95% CI, 56%-80%) for major BRVO and in 53% (95% CI, 27%-79%) for macular BRVO, with median final VA of 20/60 for both BRVO types.
Major and macular BRVOs are 2 distinct clinical entities, and initial visual status and final visual outcome in the 2 types are quite different. Overall, on resolution of macular edema, our study suggests that in both major and macular BRVO, VA and visual fields improved to a variable degree in the majority of eyes without any treatment.
了解分支视网膜静脉阻塞(BRVO)的视觉预后的自然史对于其治疗至关重要。
研究主要和黄斑 BRVO 的视觉预后的自然史。
设计、环境和参与者:1973 年至 1999 年在大学附属医院进行的观察性队列研究。该研究包括 216 例 BRVO 连续眼(144 例主要 BRVO 和 72 例黄斑 BRVO),在发病后 3 个月内就诊。
首次就诊时,所有患者均进行详细的眼科和病史以及全面的眼科评估。在初次就诊和随访时的眼科评估包括使用 Snellen VA 图表和 Goldmann 周边视野记录最佳矫正视力(VA)。
随访时的最佳矫正视力和视野结果。
在主要 BRVO 中,黄斑水肿消退的中位数时间为 21 个月,在黄斑 BRVO 中为 18 个月。总体而言,对于初始 VA 为 20/60 或更好的眼,主要 BRVO 中 75%(95%CI,63%-86%)和黄斑 BRVO 中 86%(95%CI,73%-95%)的 VA 改善或保持稳定。在初始 VA 为 20/70 或更差的眼,主要 BRVO 中 69%(95%CI,56%-80%)和黄斑 BRVO 中 53%(95%CI,27%-79%)的 VA 改善,两种 BRVO 类型的最终 VA 中位数均为 20/60。
主要和黄斑 BRVO 是两种不同的临床实体,两种类型的初始视力和最终视力结果有很大差异。总体而言,在黄斑水肿消退后,我们的研究表明,在主要和黄斑 BRVO 中,大多数眼未经任何治疗即可在不同程度上改善 VA 和视野。